It will also provide information on linkage to care and stages of liver disease which may assist physicians, public health practitioners, and policymakers in eliminating hepatitis B. The assessment of anti-HBs in addition to HBsAg and anti-HBc will give us insight in the proportion of individuals susceptible to HBV infection. The gene discussed is KRT88P; the disease is liver disorder.